All News
ACR 2017 - Day 2 Highlights
In the afternoon on Monday, the ACR ran a clinical symposium on gout. One presentation stood out, on “Asymptomatic hyperuricemia” (AH) by M. Pillinger, MD from NYU Medical School. At issue is when should AH be treated.
Read Article
Kidney transplant improves survival in GPA
Even with currently available treatment modalities, ESRD is a common complication of Granulomatosis with polyangiitis (GPA) occurring in approximately 25% of patients. Transplantation frequently used for ESRD but has not been applied widely in GPA.
SLE Clinical Trial Design and Outcome Measures
Clinical trials remain a challenge in SLE and a number of outcome measures have been used with varying success.
Two abstracts in this session sought to address novel ways to assess responses in SLE trials.
Read Article
Tech Tools for Rheumatologists Version 3.0
Low-dose Bactrim Safe with Methotrexate in AAV
A high proportion of GPA patients receive pneumocystis prophylaxis, usually with TMP-SMX (Bactrim), and drug interactions are always a concern.
Read Article
Large Vessel Vasculitis: Giant Cell Arteritis and Takayasu Arteritis
Prof Weyland started by explaining that giant cell arteritis (GCA) and Takayasu Arteritis (TA) are granulomatous forms of arteritis.
Read Article
Gut-derived TNF: Connection Between Crohn’s and SpA and Sacroiliitis
The pathogenesis between microscopic gut inflammation leading to the development of Crohn’s disease and sacroiliitis has been poorly understood. Dr. Debusschere, et al sought to understand this important link between IBD and axial SpA.
Read Article
Co-morbid Fibromyalgia
Sustenance Inspector’s 2017 Annual ACR report
There are two things I learned in rheumatology fellowship.
Never burn any bridges because everyone in rheumatology knows each other
Rheumatologists like their food
Podcast of ACR Day 1
Check out this compilation of our ACR Day 1 videocasts merged into one 59 minute podcast !
https://soundcloud.com/rheumnow/rheumnow-acr-2017-san-diego-day-1
Read Article
ACR 2017 - Day 1 Highlights
Curtis and colleagues presented a plenary session that analyzed the duration of drug holidays and the risk of subsequent fractures (FX) in women starting bisphosphonates (BP).
Read Article
RA and Cardiac Co-Morbidities
We know that cardiovascular disease (CVD) is the leading cause of death in RA and that traditional risk factors do not fully account for increased risk.
Read Article
Complementopathies: Redefining Old Diseases
From Dr. Michelle Petri’s lecture on Antiphospholipid Syndrome Updates at ACR17 Review Course on Saturday, I learned that there is now a new class of diseases called the complementopathies. This was the first time I heard of this term; how many patients did I misdiagnose who really had this and what are the ICD10 codes?!
Read Article
The Red Eye in the Rheumatology Patient
Professor Rosenbaum is well known for his expertise in rheumatic eye disease and he gave a great summary of how to approach your patient having a red eye.
Reactive Arthritis
Prof Robert Inman gave a great summary of the state of the art in reactive arthritis (ReA).
Read Article
Increasing Incidence of Paradoxical Autoimmune Disease with Biologics?
With the increasing use of biologic therapies to treat rheumatic disease has come an awareness of a small but real risk of developing de novo autoimmune disease.
Read Article
Romosozumab vs Alendronate in Postmenopausal Osteoporosis
Poster 318 presented at the ACR on Sunday morning caught attention of many, highlighting updates in phase 3 active controlled study of romosozumab vs alendronate in patients with postmenopausal osteoporosis with high risk of fracture.
Read Article
Key Takeaways from ACR Review Course
The ACR Review Course was superb once again from top to bottom, from Blue Fingers to Practical Treatment of RA. Every year I wonder if I should skip it, but each year I go. And I have never regretted it. Here are my take-home messages and “pearls” from the ACR Review Course.
Read Article
2018 Changes for MOC: More Options, But Is It Better?
Responding to criticisms that the 10 year maintenance of certification exam is expensive, time-consuming, and not reflective of clinical practice, the American Board of Internal Medicine recently issued changes to their requirements, allowing more options for physicians to recertify.
Read Article